Literature DB >> 33264543

Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them.

Philip R Krause1, Thomas R Fleming1, Ira M Longini1, Richard Peto1, Valerie Beral1, Balram Bhargava1, Alejandro Cravioto1, Jakob P Cramer1, Susan S Ellenberg1, J Peter Figueroa1, Elizabeth Halloran1, Ana M Henao-Restrepo1, Michael J Ryan1, Myron M Levine1, Martha Nason1, Hanna M Nohynek1, Stanley Plotkin1, Helen Rees1, Jerome A Singh1, Soumya Swaminathan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33264543     DOI： 10.1056/NEJMp2033538

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  27 in total

1.  Health Communication and Decision Making about Vaccine Clinical Trials during a Pandemic.

Authors:  Aisha T Langford
Journal:  J Health Commun       Date:  2020-10-02

2.  Nodosome Inhibition as a Novel Broad-Spectrum Antiviral Strategy against Arboviruses, Enteroviruses, and SARS-CoV-2.

Authors:  Daniel Limonta; Lovely Dyna-Dagman; William Branton; Valeria Mancinelli; Tadashi Makio; Richard W Wozniak; Christopher Power; Tom C Hobman
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191

3.  A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination.

Authors:  Stefan Handtke; Martina Wolff; Carlo Zaninetti; Jan Wesche; Linda Schönborn; Konstanze Aurich; Lena Ulm; Nils-Olaf Hübner; Karsten Becker; Thomas Thiele; Andreas Greinacher
Journal:  Blood       Date:  2021-07-01       Impact factor: 25.476

4.  Vaccine scarcity in LMICs is a failure of global solidarity and multilateral instruments.

Authors:  Irene Torres; Daniel Lopez-Cevallos; Osvaldo Artaza; Barbara Profeta; JaHyun Kang; Cristiani Vieira Machado
Journal:  Lancet       Date:  2021-05-15       Impact factor: 79.321

Review 5.  COVID-19: vaccination problems.

Authors:  Harald Brüssow
Journal:  Environ Microbiol       Date:  2021-05-14       Impact factor: 5.476

6.  Clinical Equipoise in COVID-19 Vaccine Candidate Trials.

Authors:  Rafael Dal-Ré
Journal:  J Clin Pharmacol       Date:  2021-07-20       Impact factor: 2.860

7.  Next steps for efficacy evaluation in clinical trials of COVID-19 vaccines.

Authors:  Hu-Dachuan Jiang; Li Zhang; Jing-Xin Li; Feng-Cai Zhu
Journal:  Engineering (Beijing)       Date:  2021-05-19       Impact factor: 7.553

8.  Ethical Considerations for Unblinding and Vaccinating COVID-19 Vaccine Trial Placebo Group Participants.

Authors:  Jenna Rose Stoehr; Alireza Hamidian Jahromi; Clayton Thomason
Journal:  Front Public Health       Date:  2021-06-24

9.  SARS-CoV-2 Variants and Vaccines.

Authors:  Philip R Krause; Thomas R Fleming; Ira M Longini; Richard Peto; Sylvie Briand; David L Heymann; Valerie Beral; Matthew D Snape; Helen Rees; Alba-Maria Ropero; Ran D Balicer; Jakob P Cramer; César Muñoz-Fontela; Marion Gruber; Rogerio Gaspar; Jerome A Singh; Kanta Subbarao; Maria D Van Kerkhove; Soumya Swaminathan; Michael J Ryan; Ana-Maria Henao-Restrepo
Journal:  N Engl J Med       Date:  2021-06-23       Impact factor: 176.079

10.  Role of Pegylated Interferon in Patients with Chronic Liver Diseases in the Context of SARS-CoV-2 Infection.

Authors:  Sheikh Mf Akbar; Mamun A Mahtab; Julio C Aguilar; Md H Uddin; Md Sakirul I Khan; Osamu Yoshida; Eduardo Penton; Guillen N Gerardo; Yoichi Hiasa
Journal:  Euroasian J Hepatogastroenterol       Date:  2021 Jan-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.